bpc-157 clinical trials human safety evidence fda status Peptides, explained: Answers to your top questions The Stable Gastric Pentadecapeptide BPC

Beyond that landmark study, the evidence base includes research showing GHK-Cu enlarges hair follicle size, extends the anagen (active growth) phase, stimulates dermal papilla cells (the cells that control follicle activity), promotes angiogenesis (blood vessel growth) to the scalp, and reduces the DHT-related inflammation that causes follicle miniaturization in androgenetic alopecia

CONCERN #13: INFLAMMATORY SKIN CONDITIONS Description: Conditions like acne, rosacea, and eczema are often external manifestations of internal inflammation, particularly in the gut

FDA www.accessdata.fda.gov/drugsatfda_docs/nda/2005/21-332_Symlin%20Injection_prntlbl.pdf (2005)

The Decision: Who Should Try It, Who Should Skip A five-question pre-use audit Before you open the first sealed needle head, answer five questions plainly